Zoetis Inc.
Market Cap
$31.1B
Global Rank
#300
All-Time High
$97.5B
2021-12-31
Total Growth
+0%
since 2026
Market Cap Context
- Larger than 18% of the 367 companies we track (globally).
- Equivalent to 0.1% of United States's GDP (2025 data).
- Just above: #299 Crown Castle Inc. ($31.3B)
- Just below: #301 adidas AG ($30.7B)
- Best year: 2019 (+56%). Worst year: 2026 (-40%).
Zoetis Inc. Financial Breakdown (FY 2025)
Source: Yahoo Finance โ ZTS annual filings (2025) โ$9.5B revenue ยท $3.6B operating income ยท $2.7B net income
- โOperating margin: 38.0% on $9.5B in revenue.
- โR&D is 7.4% of revenue ($0.7B).
- โNet income margin: 28.2% โ $2.7B in profit.
- โFree cash flow: $2.3B (24.1% of revenue).
Cost / Operating Expenses
Total operating expenses $5.9B
Total
$5.7B
Capital Expenditures
$0.6B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$2.3B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
About Zoetis Inc.
Zoetis Inc. (/zล-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.
Zoetis Inc. Market Cap History (2026โ2026)
Zoetis Inc. vs Sector Peers by Market Cap
Compare Zoetis Inc.
Ranking History
| Year | Market Cap | Rank | YoY Change |
|---|---|---|---|
| 2026 | $31.1B | #300(โ55) | -40.5% |
| 2025 | $52.3B | #245(โ51) | -21.8% |
| 2024 | $66.8B | #194(โ55) | -16.6% |
| 2023 | $80.2B | #139(โ13) | +35.9% |
| 2022 | $59.0B | #152(โ49) | -39.5% |
| 2021 | $97.5B | #103(โ22) | +48.3% |
| 2020 | $65.8B | #125(โ9) | +25.8% |
| 2019 | $52.3B | #134(โ24) | +55.7% |
| 2018 | $33.6B | #158(โ43) | +19.4% |
| 2017 | $28.1B | #201(โ6) | +35.5% |
| 2016 | $20.7B | #207 | +12.6% |
| 2015 | $18.4B | #207(โ9) | +12.2% |
| 2014 | $16.4B | #216(โ5) | +32.8% |
| 2013 | $12.4B | #221 |
Other Healthcare Companies
FAQ
What is Zoetis Inc.'s market cap?
Zoetis Inc. (ZTS) has a market capitalization of $31.1B, making it the #300 largest company in the world by market cap.
What was Zoetis Inc.'s highest market cap?
Zoetis Inc.'s all-time high market cap was $97.5B, reached in 2021-12-31. Its highest rank was #103 in 2021.
What sector is Zoetis Inc. in?
Zoetis Inc. is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry. It is based in United States.
How has Zoetis Inc.'s market cap changed over time?
Zoetis Inc. has been tracked since 2026. Its market cap has grown by 0% from $31.1B in 2026 to $31.1B today.